![](https://cdn.sanity.io/images/0vv8moc6/onclive/72f84d39d59c9f40378762b46932d409be8998ab-1200x1200.jpg?fit=crop&auto=format)
Real-World Outpatient CAR T-Cell Administration Insights Show Improved Safety and Feasibility in NHL
Advances in the management of CAR T-cell therapy–related toxicities, including cytokine release syndrome (CRS) and immune effector cell–associated neurotoxicity syndrome (ICANS), have substantially improved the safety and feasibility of outpatient …